Zegalogue
Zegalogue (dasiglucagon) is a glucagon receptor agonist indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older. It acts by stimulating the release of glucose from the liver.
Dosage by Body Weight
The recommended dose is 0.6 mg injected subcutaneously into the abdomen, thigh, gluteal area, or outer upper arm. An additional dose of 0.6 mg may be administered using a new prefilled syringe or autoinjector if the patient does not respond within 15 minutes.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age.
- Body Weight
- 5-7 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy have not been established in patients under 6 years of age.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established in patients under 6 years of age. |
| 5-7 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established in patients under 6 years of age. |
| 8-10 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established in patients under 6 years of age. |
| 11-15 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established in patients under 6 years of age. |
| 16-20 kg | Not routine | Use only if prescribed | Safety and efficacy have not been established in patients under 6 years of age. |
Formulation
Injection (Prefilled Syringe)Injection (Autoinjector)
Purpose
Treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and older.
Generic Name
DasiglucagonScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.